These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 4080962
1. [Changes in carcinoembryonic antigen and tissue polypeptide antigen in monitoring the post-operative course of some tumor types]. Ciaccio B, Caponi A, Cappetti P, Fanciullacci A, Bartoli P, Berti P. Quad Sclavo Diagn; 1985 Jun; 21(2):199-205. PubMed ID: 4080962 [Abstract] [Full Text] [Related]
4. [Tissue polypeptide and carcinoembryonic antigens in patients with breast cancer]. Polevaia EB, Tkacheva GA, Ivanov VM, Koposova TL. Vopr Onkol; 1984 Jun; 30(3):9-13. PubMed ID: 6710954 [Abstract] [Full Text] [Related]
5. Significance of carcinoembryonic and tissue polypeptide antigen determination in the diagnosis of metastases in breast cancer. Kausitz J, Hupka S, Makaiová I, Michalíková B, Urbanová M, Bohunický L, Belovicová C. Neoplasma; 1986 Jun; 33(4):471-6. PubMed ID: 3762808 [Abstract] [Full Text] [Related]
7. [Clinical utility of tumor markers in gastric and colon cancer]. Ogawa K, Naritaka Y, Koyama N, Ohtani Y, Kawata H, Yagawa H, Kajiwara T, Sakakibara N. Gan No Rinsho; 1985 May; 31(6 Suppl):638-47. PubMed ID: 3861884 [Abstract] [Full Text] [Related]
8. [Clinical evaluation of tissue polypeptide antigen in patients with esophageal, stomach and colon cancer]. Ogoshi K, Kondo Y, Akiba Y, Sugihara T, Ko S, Noto T, Makuuchi H, Tajima T, Mitomi T. Gan No Rinsho; 1984 Aug; 30(10):1299-302. PubMed ID: 6481966 [Abstract] [Full Text] [Related]
10. [Pretreatment evaluation of CA 72.4 in patients with carcinoma of the stomach (0-IV stage) versus CEA, TPA, CA 19-9, FER]. Buda F, Aragona P, Giani G, Sisto R, Di Nardo G, Binotto F, Gangemi P, De Zerbi T, Gentile G, Papadia A. G Ital Oncol; 1989 Aug; 9(2-3):67-72. PubMed ID: 2767730 [Abstract] [Full Text] [Related]
11. [Clinical study of the measurement of tissue polypeptide antigen in patients with breast cancer]. Fukunaga M, Otsuka N, Yanagi M, Sone T, Muranaka A, Yanagimoto S, Tomomitsu T, Morita R, Ohama T, Sonoo H. Gan No Rinsho; 1985 Jul; 31(8):923-8. PubMed ID: 4032770 [Abstract] [Full Text] [Related]
12. [Advantages and limitations of combined assays of 4 serum markers in various types of malignant neoplasms]. Lanza E, Coda C, Ramella S, Ciambellotti E, Moro G, Cartia GL. Minerva Med; 1986 Sep 15; 77(34-35):1521-5. PubMed ID: 3463886 [Abstract] [Full Text] [Related]
15. [Association of ferritin with the CEA test in post-operative monitoring of colo-rectal, breast and stomach carcinomas]. Fanciullacci A, Cappetti P, Ciaccio B, Caponi A, Bartoli P, Taviani R, Berti P. Quad Sclavo Diagn; 1984 Dec 15; 20(4):355-63. PubMed ID: 6537546 [Abstract] [Full Text] [Related]
17. [CEA and TPA in cancer of the breast. Findings and criteria of use]. Torres Avisbal M, Ruíz de Almodovar Rivera JM, Villalba Moreno J, Olea Serrano N, Padilla Bolivar O, Pedraza Muriel V. Rev Esp Oncol; 1985 Dec 15; 32(2):265-80. PubMed ID: 3843460 [Abstract] [Full Text] [Related]
18. [Association of oncological markers in colon cancer]. Ciarniello P, Latella G, Fusco A, Giannoni MF, Citone G, Caprilli R. Minerva Med; 1986 Mar 31; 77(13):499-500. PubMed ID: 3458033 [No Abstract] [Full Text] [Related]
20. [Ferritin, CEA and TPA as tumor markers in breast neoplasms]. Bonanni F, Folco U, Giudici Cipriani A, Buffa E, Amedeo A, Bertolotto M, Rembado R, Barbetti V, Guglieri F. Minerva Med; 1985 Sep 15; 76(34-35):1533-4. PubMed ID: 4034052 [Abstract] [Full Text] [Related] Page: [Next] [New Search]